Blood test may forecast kidney outcome in sepsis patients
NCT ID NCT07295392
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether levels of a protein called uromodulin in the blood can help predict how well kidneys recover in adults with sepsis-related acute kidney injury. Researchers will measure uromodulin at the start, after one week, and at hospital discharge in 30 patients. The goal is to see if this protein can forecast complete kidney recovery, length of ICU stay, or death within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict which sepsis patients with kidney injury will recover fully versus develop chronic kidney disease.
- What could go wrong
- This is a small, early observational study with only 30 participants. The findings may not apply to all patients or lead to any treatment changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which emergency dialysis saves more lives? a new study investigates
- A simple sensor on the back could warn of kidney danger during heart surgery
- Can a common blood thinner be safe for ICU patients with liver issues?
- A urine test that could foresee kidney danger in the ICU
- Which citrate solution minimizes metabolic chaos in kidney therapy?
- A wearable sensor might spot kidney danger before it strikes